» Authors » A Allahabadia

A Allahabadia

Explore the profile of A Allahabadia including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 435
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hussain Y, Hookham J, Allahabadia A, Balasubramanian S
Endocrine . 2017 May; 56(3):568-578. PMID: 28478488
Purpose: Treatment options in Graves' disease are clearly defined, but management practices and the perceptions of success are varied. The outcomes of treatment in large consecutive cohorts of Graves' disease...
2.
Walker J, Shillo P, Ibbotson V, Vincent A, Karavitaki N, Weetman A, et al.
Eur J Endocrinol . 2013 Apr; 168(6):913-7. PMID: 23554450
Objective: For patients who remain hypothyroid despite the administration of what would seem adequate doses of levothyroxine (L-T4), the underlying cause can be difficult to determine. The possibility of a...
3.
Manji N, Carr-Smith J, Boelaert K, Allahabadia A, Armitage M, Chatterjee V, et al.
J Clin Endocrinol Metab . 2006 Sep; 91(12):4873-80. PMID: 16968788
Context: Both genetic and environmental factors contribute to susceptibility to Graves' disease (GD) and Hashimoto's thyroiditis (HT), as well as disease manifestations. Objective: The objective of the study was to...
4.
Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough S, et al.
Clin Endocrinol (Oxf) . 2004 May; 60(6):671-5. PMID: 15163328
Objective: Propylthiouracil treatment of Graves' disease has been postulated to provoke antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. We aimed to investigate whether carbimazole therapy was also associated with increased risk of...
5.
Allahabadia A, Weetman A
J Endocrinol Invest . 2003 Nov; 26(7 Suppl):31-8. PMID: 14604064
Modern assays for TSH and for free thyroid hormones have significantly reduced the need for dynamic testing of the hypothalamo-pituitary-thyroid axis in patients with biochemical thyroid dysfunction. However, under certain...
6.
Allahabadia A, Heward J, Nithiyananthan R, Gibson S, Reuser T, Dodson P, et al.
Lancet . 2001 Oct; 358(9286):984-5. PMID: 11583755
Up to half of patients with Graves' hyperthyroidism have signs of thyroid associated ophthalmopathy, but the factors that cause this disorder are unknown. We investigated two major genetic susceptibility loci...
7.
Heward J, Nithiyananthan R, Allahabadia A, Gibson S, Franklyn J, Gough S
J Clin Endocrinol Metab . 2001 Aug; 86(8):3861-3. PMID: 11502824
Graves' disease (GD) is an autoimmune thyroid disease of unknown etiology, although predisposition to the development of this disease is thought to be caused by both genetic and environmental factors....
8.
Allahabadia A, Daykin J, Sheppard M, Gough S, Franklyn J
J Clin Endocrinol Metab . 2001 Aug; 86(8):3611-7. PMID: 11502786
There is little consensus regarding the most appropriate dose regimen for radioiodine (131I) in the treatment of hyperthyroidism. We audited 813 consecutive hyperthyroid patients treated with radioiodine to compare the...
9.
Nithiyananthan R, Heward J, Allahabadia A, Barnett A, Franklyn J, Gough S
J Clin Endocrinol Metab . 2000 Mar; 85(3):1320-2. PMID: 10720083
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare monogenic autoimmune disease with endocrine components including type 1 diabetes, adrenal failure, and thyroid dysfunction, with major autoantibodies directed against adrenal, pancreas, and...
10.
Allahabadia A, Daykin J, Holder R, Sheppard M, Gough S, Franklyn J
J Clin Endocrinol Metab . 2000 Mar; 85(3):1038-42. PMID: 10720036
The response to treatment in Graves' hyperthyroidism is unpredictable, and factors postulated to predict outcome have not generally proved clinically useful or been widely adopted in clinical practice. We audited...